BICUCULLINE MICROINJECTIONS INTO THE VENTRAL TEGMENTAL AREA OF THE RAT - ALTERATION OF SELF-STIMULATION THRESHOLDS AND OF CYTOCHROME-OXIDASE ACTIVITY IN THE BRAIN
G. Sandner et al., BICUCULLINE MICROINJECTIONS INTO THE VENTRAL TEGMENTAL AREA OF THE RAT - ALTERATION OF SELF-STIMULATION THRESHOLDS AND OF CYTOCHROME-OXIDASE ACTIVITY IN THE BRAIN, Behavioural brain research, 79(1-2), 1996, pp. 145-151
Abuse of drugs that potentiate GABAergic neurotransmission, namely ben
zodiazepines, is difficult to understand because this potentiation sho
uld elicit, among other effects, a decrease in activity within the mes
olimbic system. Abuse of benzodiazepines is difficult to understand si
nce the opposite, namely an increase in mesolimbic activity, has been
implicated in drug abuse as well as in the rewarding effect of direct
mesolimbic stimulation. In order to evaluate how the activity of the m
esolimbic system depends on mesolimbic GABAergic influence, a GABA, re
ceptor antagonist, bicuculline methiodide, was unilaterally injected i
nto the ventral tegmental area and its effect on self-stimulation thre
sholds derived from stimulations applied to the same area was evaluate
d. Microinjection of 15, 20 and 30 ng increased the stimulation thresh
old. This decrease in stimulation efficiency lasted no more than 15 mi
n after which baseline levels were obtained. Such a decrease is parado
xical considering that the manipulation should have released the ventr
al tegmentum from a tonic inhibitory influence. The metabolic conseque
nces of repeated injections of 30 ng bicuculline were furthermore eval
uated by cytochrome oxidase histochemistry. The staining was found to
be weak around the injection site and dense in the ipsilateral nucleus
accumbens. Release of a tonic GABAergic inhibition added to some cyto
toxic damage probably resulted in an increased metabolic activity of t
his system. The presently reported paradoxical response of the ventral
tegmentum and mesolimbic system to a GABAergic challenge may account
for the paradoxical relationship between some behavioral properties of
the mesolimbic system and GABAergic drugs.